Today’s AI Top Pick: RH

9/15/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live RH price forecast →

Today's pick · Low Float Bullish Consensus Deep RotationRHBUY NOW8.7 / 109/15/2026

RH is the cleanest multi-timeframe bullish setup in the pool with fundamentals that actually support the tape. All three available timeframes (4h, 1d, 1wk) point sharply higher: 4h forecasts +32.16%/+39.39%/+57.03%, 1d forecasts +5.97%/+21.09%/+46.4%, and 1wk +14.41%/+73.98%/+132.52% short/mid/long. Bullish_prob = 1.0 and near_term_bullish = 1.0 — the model has full conviction across horizons, which is rare in this list. Crucially, you are NOT chasing. Price sits at pos_in_21bar_range_pct = 0 on the 1d and just 2.35 on the 4h, drawdown from the 21-bar high is -23.96% (1d) / -21.3% (4h), and daily RSI is 31.93 — oversold. That is textbook 'entry at the low of a bullish forecast' rather than late chase. Fundamentals back it up: PEG 0.53, fwdPE 14.86, ROE 280.72, EPS Next Y +81.27%, targetUpsidePct +19.8%, and shortFloat 31.5% (squeeze fuel on any bounce). The Q2 2026 earnings call flagged margin pressure but was paired with the RH Estates launch and international expansion — a growth catalyst, not a guidance cut or dilution event. That's a mixed-but-net-constructive headline backdrop rather than a landmine. Compared to KAI (weekly forecast negative -7.37/-3.91, breaking multi-tf agreement) and CDNL (only 1d timeframe available, no confirmation), RH is the only name with unanimous multi-tf bullish alignment, deep pullback entry, top-tier bullish_prob, AND analyst-supported growth math. Today is the entry because you're stacking: (1) oversold RSI, (2) 0% position in daily range (mean-reversion pressure), (3) forecasted moves that are multiples of typical volatility, and (4) a 31.5% short float that amplifies any reversal. Waiting risks buying after the first squeeze leg.

Entry zone
$132.50 - $135.50 (scale in around current $133.75, add on any dip to $130)
Stop loss
$122.00 (below 21-bar low, roughly -8.8% risk; invalidates the mean-reversion thesis)
First target
$155 (near-term 4h/1d forecast convergence, ~+16%)
Longer target
$195-$210 (1wk fc_mid +73.98% / fc_long +132.52% zone; trail after $175)
Risks
  • Debt/Equity 34.14 is extreme — any macro/consumer-cyclical shock hits RH's balance sheet harder than peers
  • Q2 margin pressure was explicitly called out; if RH Estates ramp disappoints, fwdPE 14.86 re-rates lower fast
  • Analyst recom 2.57 (only 'hold') and targetUpsidePct just 19.8% — Street is not on board yet, meaning limited upgrade fuel
  • shortFloat 31.5% cuts both ways: fuel on the way up, but coordinated bearish thesis exists — a fresh short report could crater it
  • Weekly drawdown from high is -31.81%; if $122 breaks, next real support is well below (~$105-110)
Honorable mentions
KAIRSI 24.77 (deeply oversold), 1d/4h/1h forecasts all positive (+14.9-20.39% mid/long), pos_in_range 1.58% on 1d, solid fundamentals (profitMargin 9.52, salesYoY 12.5, fwdPE 19.04). Downgraded because 1wk forecast is negative (-7.37/-3.91), breaking multi-tf unanimity, and CEO succession announcement introduces transition-risk overhang.
CDNLBest fundamentals+news combo — recom 1.0, salesYoY 89.75%, fwdPE 15.02, targetUpsidePct 75.9%, and a fresh ~$40M Walmart contract award. 1d forecasts +38.6%/+46.98% mid/long with pos_in_range 0.95%. Only reason it's not #1: single timeframe available (no 1h/4h/1wk confirmation), so multi-tf agreement can't be verified.
Full ranking (15)
#SymbolVerdictScoreRead
1RHBUY NOW8.7Unanimous multi-tf bullish (4h/1d/1wk), oversold RSI 31.93, pos 0% on daily, 31.5% short float — deep-value squeeze setup with real fundamentals.
2KAIBUY NOW7.8Oversold RSI 24.77, 1h/4h/1d forecasts +12-20%, pos_in_range 1.58% — clean pullback buy but weekly forecast negative.
3CDNLBUY NOW7.5$40M Walmart contract + salesYoY 89.75% + 1d fc_long +46.98% at pos 0.95%; lacks multi-tf confirmation.
4MORNBUY PULLBACK6.2Best fundamentals (score 7.25), but bullish_prob 0.2 and 4h forecasts negative — wait for a real dip.
5GRCEBUY PULLBACK6.0Biotech with recom 1.0, targetUpsidePct 162%, 4h fc_short +46.31%; but 1d at pos 100% — chase risk.
6SERBUY PULLBACK5.8BTIG Buy reiterated, cohort-1 readout positive, but 4h at pos 100% and short-term forecasts negative.
7QNTMBUY PULLBACK5.6Fresh FDA clearance for MS trial is real catalyst, but 1wk fc_short -81.97% signals near-term chop.
8AZOWAIT5.4Solid fundamentals but 1h pos 100% (top of range) and 1wk drawdown -17.49% — chasing risk.
9DRMAWAIT5.21d fc_long +150% and 1wk forecast is +15,894% (data outlier — untrustworthy).
10NXTCBUY PULLBACK5.01wk fc_long +73.39% with dd -29.06%, but only 2 timeframes and near_term_bullish 0.2.
11XTLBWAIT4.8Multi-tf bullish and near_term_bullish 0.8, but $10M mcap and no fundamentals — pure speculation.
12RGNTWAIT4.6Positive GelrinC update but only 1d timeframe, perfYtd -72.11% shows broken tape.
13CNCKWAIT4.4Coincheck 1wk fc_long +428% but near_term_bullish 0 and 4h/1d pos 0% (falling knife).
14MMAWAIT4.01d fc_long +109% but 1wk forecasts negative and $10M mcap penny name.
15AKTXAVOID3.81wk forecasts show -100% across all horizons — likely dilution/delisting risk flag.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.